Christopher Peetz

2023

In 2023, Christopher Peetz earned a total compensation of $6.5M as Chief Executive Officer at Mirum Pharmaceuticals, a 47% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$633,600
Option Awards$3,383,920
Salary$660,000
Stock Awards$1,761,000
Other$13,200
Total$6,451,720

Peetz received $3.4M in option awards, accounting for 52% of the total pay in 2023.

Peetz also received $633.6K in non-equity incentive plan, $660K in salary, $1.8M in stock awards and $13.2K in other compensation.

Rankings

In 2023, Christopher Peetz's compensation ranked 65th out of 2,983 executives tracked by ExecPay. In other words, Peetz earned more than 97.8% of executives.

ClassificationRankingPercentile
All
65
out of 2,983
98th
Division
Manufacturing
32
out of 1,637
98th
Major group
Chemicals And Allied Products
24
out of 906
97th
Industry group
Drugs
23
out of 869
97th
Industry
Pharmaceutical Preparations
16
out of 627
97th
Source: SEC filing on April 23, 2024.

Peetz's colleagues

We found two more compensation records of executives who worked with Christopher Peetz at Mirum Pharmaceuticals in 2023.

2023

Eric Bjerkholt

Mirum Pharmaceuticals

Chief Financial Officer

2023

Peter Radovich

Mirum Pharmaceuticals

Chief Operating Officer

News

In-depth

You may also like